Sernova Corp T.SVA

Locking in PROFITS

[stockhunter1]

Monday morning I am going to start to lighten up my posistion.  I will put my first 100,000 block for sale at $5 bucks as this is what I feel is a fair valuation for Sernova when compared to some of our peers. My second 100,000 block will be at $6 bucks, my third block of 100,000 will be at $7 bucks.  Check your level 2 in the morning you will see I have began to sell my blocks and am setting the bar very high. I will hold the majority of my posisition ...and wait for big pharmas and the ensuing bidding war for this Truely Disruptive Technology.  Re-read this single sentence again form our Jan 15 news until you know the TRUE value of YOUR SHARES!!

       "This patient has now been insulin free (requiring no injectable insulin) for nine months with optimal glucose control." 

The Big companies that are interested in our [removable ] cell pouch [ house ] will re-read this single sentence many times today in virtual board rooms as they also try and determine FAIR VALUE!!  Interesting times are here... Good Luck to ALL Longs!!

[rixpix]

"When compared to some of our Peers"....  Compared to who? You can't place a realistic value of 5 bucks on this from one patient. Need more test results and analysis before coming to that conclusion.

[Mickey2]

we have 2 peers VIACYTE with a market cap of $ 240MM US SEMMA   with a market cap of $ 950MM US both VIACYTE and SEMMA have no functioning cell pouch... both are years behind us.

[stockhunter1]

Rixpix...please look at Semma [ bought in 2020]  and Sigilion. [ public in 2020 ]  Use an educated eye as to what they have and their market cap VS Sernovas. Then think about what Sernova has. You may find that $5 bucks is on the cheap side?  It is not necessary to bash my valuation ...listen well to Dr.Tolekis in the presentation below...then bash him, if you feel justified ?? in

[rixpix]

Stockhunter, I in no way have bashed your valuation, and nothing would make me happier than for you to be right. I just feel we're not there yet, that's why I disagreed. Glta of us

[Redbaron2211]

Rixpix,  We have 5 patients all expressing insulin and trending towards the first patient.  It is more than fair to compare to peers.  If anything, peers cant be compared to Sernova because they are still preclinical and haven't even shown that their cells can be vascularized let alone expressing insulin or other blood-clotting proteins  .    Sgtx tradded in the

[rixpix]

Red, totally agree with everything you said. I just feel a billion $$ valuation with only one report is too early. But like I said before, nothing would make me happier than to be wrong. Heck, gimme 2 billion valuation next week.  Glta of us!